课题基金 / 基金详情

Phenotype MicroArrays for Drug Toxicity Screening

Phenotype MicroArrays for Drug Toxicity Screening
用于药物毒性筛查的表型微阵列
批准号:
6841912
负责人:
BARRY RONALD BOCHNER
金额:
$65.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-09 至 2008-07-31

项目摘要

项目成果

BARRY RONALD BOCHNER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在这第二阶段SBIR补助金,我们建议开发我们的表型微阵列(PM)技术成为一个高通量筛选(HTS)检测药物毒性。该提案解决了药物发现中对更快、更简单、更便宜的技术的关键需求,这些技术可以评估候选药物的潜在毒理学和作用机制。Biolog已经开发出一种原型技术,可用于药物毒性的体外筛选。它被设计用于选择代表通常表现出毒性的不同器官和组织的人类细胞系。该技术可以以简单易用的HTS格式测量细胞的数千个生理参数。该技术的核心是一个化学和图像分析系统,可以检测在不同生理条件下培养的细胞呼吸活动的变化。用Biolog的自动化OmniLog仪器检测比色反应,测量细胞代谢活性的变化。PM允许为检查的每种药物和细胞系生成信息丰富的比色图案。当在PM中测试药物时,比色模式会发生变化,并且使用模式识别技术,我们可以将PM中的颜色变化与药物的作用模式和副作用联系起来。这种模式是药物作用的指纹。这种基于细胞的毒理学测试方法的一个独特之处在于,我们可以看到药物在细胞近2000种不同生理状态下对细胞的影响。测试细胞或动物的替代方法仅在健康和增殖状态下测试毒理学。另一个独特的方面是,该技术还可以测试药物组合,并可以提供非常有用的协同作用和拮抗作用信息。在该项目的第二阶段,我们建议将可进行的PM测试集从目前的600个扩展到大约2000个,使该技术自动化和自动化,然后通过测试2000种已知类别和毒性的化学品来构建化学指纹的初始数据库。除了在毒理学中的应用外,该技术还可用于研究细胞生物学、代谢疾病和基因功能的基础研究,以及用于细胞系和生物工艺开发的QC测试的应用细胞生物学。
英文摘要
DESCRIPTION (provided by applicant): In this Phase II SBIR grant, we propose to develop our Phenotype MicroArray (PM) technology into a high throughput screening (HTS) assay for drug toxicity. The proposal addresses a key need in drug discovery for faster, simpler, and less expensive technologies that can assess drug candidates for potential toxicology as well as mechanism of action. Biolog has developed a prototype technology that can be employed for in vitro screening of drug toxicity. It is designed to work with human cell lines selected to represent the different organs and tissues where toxicity is typically exhibited. The technology can measure thousands of physiological parameters of a cell in a simple-to-use HTS format. The core of the technology is a chemistry and image analysis system that detects changes in respiratory activity of cells cultured under different physiological conditions. The changes in metabolic activity of the cell are measured as a colorimetric response detected with Biolog's automated OmniLog instrument. PMs allow for an information-rich colorimetric pattern to be generated for each drug and cell line examined. When a drug is tested in the PM, the colorimetric pattern changes and using pattern recognition technology, we can relate the color changes in the PM to the mode of action and side effects of the drug. The pattern is a fingerprint of that drug's action. A unique aspect of this cell-based approach to toxicological testing is that we can see the effect of the drug on cells under nearly 2000 diverse physiological states of the cell. Alternative methods of testing cells or animals only test for toxicology in a healthy and proliferative state. Another unique aspect is that the technology also tests drug combinations and can provide highly useful synergy and antagonism information. In Phase II of this project we propose to expand the set of PM tests that can be performed from the current set of 600 to approximately 2000, miniaturize and automate the technology, and then construct an initial database of chemical fingerprints by testing 2000 chemicals of known classes and toxicities. In addition to applications in toxicology, this technology will be useful in basic research to study cell biology, metabolic diseases, and gene function, and in applied cell biology for QC testing of cell lines and bioprocess development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phenotype MicroArray Analysis of Fastidious Pathogens
  • 批准号:
    7933126
  • 项目类别:
  • 资助金额:
    $92.3万
  • 财政年份:
    2009
  • 负责人:
    BARRY RONALD BOCHNER
  • 依托单位:
Phenotype MicroArray Analysis of Fastidious Pathogens
  • 批准号:
    7496389
  • 项目类别:
  • 资助金额:
    $53.98万
  • 财政年份:
    2004
  • 负责人:
    BARRY RONALD BOCHNER
  • 依托单位:
Phenotype MicroArray Analysis of Fastidious Pathogens
  • 批准号:
    7273799
  • 项目类别:
  • 资助金额:
    $47.08万
  • 财政年份:
    2004
  • 负责人:
    BARRY RONALD BOCHNER
  • 依托单位:
Phenotype MicroArray Analysis of Fastidious Pathogens
  • 批准号:
    6833552
  • 项目类别:
  • 资助金额:
    $27.7万
  • 财政年份:
    2004
  • 负责人:
    BARRY RONALD BOCHNER
  • 依托单位:
海外基金